-
Pluslife Secures Indonesian Import License for Groundbreaking Mycobacterium Tuberculosis Nucleic Acid Test Card
Recently, Pluslife's self-developed rapid molecular diagnostic test card for tuberculosis, utilizing tongue swab samples, was awarded an import medical device license by the Indonesian government. This milestone marks a significant breakthrough following the earlier certification of Pluslife’s sputum sample TB diagnostic technology.
넶93 2024-09-09 -
Pluslife Biotech Founder, Prof. Songyang Speaks on Next-Generation Molecular POCT Technology at the International Health Industry Forum of Boao Forum for Asia
From April 20th to 21st, the International Health Industry Forum of Boao Forum for Asia was held in Beijing, China. The event brought together decision-makers, healthcare providers, experts, and investors to promote global innovation and development in healthcare. The Founder of Pluslife Biotech, Prof. SONGYANG Zhou spoke on the panel “Diagnostic Companies and How They Engage with Global Public Health” to share ideas on how Next-Generation Molecular POCT
넶62 2024-08-05 -
Pluslife MiniDock Achieves Outstanding Accuracy and Usability in PATH APOLLO Project
In the recent APOLLO evaluation project conducted at the PATH laboratory in Seattle, Pluslife MiniDock has gained satisfactory results in terms of test performance and usability, confirming its testing accuracy and strong usability in LMICs (Low- and Middle-Income Countries).
넶80 2024-08-05 -
Pluslife Biotech CEO, Mr. Chen, Shared Insights into Molecular POCT Empowering Global Primary Healthcare at Pujiang Innovation Forum
From September 9th to 11th, 2023, the 16th Pujiang Innovation Forum took place in Shanghai, China. Mr. CHEN Chong, the CEO of Pluslife Biotech, spoke on the panel titled “New Applications and Markets for Innovative Technologies Accelerating Global Health and Development” and shared insights into how molecular Point-of-Care diagnostics empower global primary healthcare.
넶55 2024-08-05 -
Pluslife Biotech Founder, Prof. Songyang Contributes Viewpoints on Infectious Disease Prevention at the Symposium on Global Health
The 4th Symposium on Global Health was recently held in Beijing on September 14-15, 2023. The founder and head scientist of Pluslife Biotech, Prof. SONGYANG Zhou, gave a speech on the topic “New technologies for the surveillance and detection of infectious diseases” to deliver an outlook on strengthening global infectious disease diagnosis and surveillance with revolutionary molecular POCT technology.
넶24 2024-08-05 -
Pluslife Tongue-Swab MTB Diagnostics Presented at the Union World Conference on Lung Health
Last week in Paris, Dr. Zhou Songyang, the founder of Pluslife, and Mr. Chong Chen, the CEO, participated in the Union World Conference on Lung Health. During the event, Pluslife MTB testing was presented by FIND in the session titled "Unlocking the Potential of Tongue Swabs to Expand Access to TB Testing."
넶49 2024-08-05
